Recombinogenic and mutagenic effects of the antitumor antibiotic bleomycin in Aspergillus nidulans
Related Experiment Videos
Abstract:
Bleomycin, an antibiotic and antineoplastic drug that inhibits DNA synthesis and causes several types of chromosomal aberration, was found to increase mitotic recombination in Aspergillus nidulans. Heterozygous prototrophic diploid strains grown on media containing bleomycin produced significant increases of yellow and white sectors compared with controls. Further, the increased colour segregants were due to mitotic crossing-over, whereas the non-dis junctional segregants remained at the control level. Bleomycin also induced point mutations in the methionine-suppressor system of the methGl biAl strain of Aspergillus nidulans. Conidia treated in suspension with various concentrations of bleomycin increased the methionine-independent mutants 30-fold and more.
Insights
Bleomycin, an antineoplastic drug, significantly increases mitotic recombination and induces point mutations in Aspergillus nidulans. This DNA-damaging agent promotes chromosomal aberrations, impacting genetic stability in this model organism.
Area of Science:
- Genetics
- Molecular Biology
- Mycology
Background:
- Bleomycin is an antibiotic and antineoplastic agent known to inhibit DNA synthesis.
- It is also recognized for inducing various chromosomal aberrations.
- Aspergillus nidulans is a widely used model organism for genetic studies.
Purpose of the Study:
- To investigate the effect of bleomycin on mitotic recombination in Aspergillus nidulans.
- To determine if bleomycin induces point mutations in specific genetic systems.
- To elucidate the mechanisms by which bleomycin affects genetic stability.
Main Methods:
- Culturing heterozygous prototrophic diploid strains of Aspergillus nidulans on bleomycin-containing media.
- Analyzing the frequency of yellow and white sectors as indicators of mitotic recombination.
- Treating conidia with varying concentrations of bleomycin in suspension.
- Assessing the induction of methionine-independent mutants in a specific strain (methGl biAl).
Main Results:
- Bleomycin significantly increased the occurrence of yellow and white sectors, indicating enhanced mitotic recombination.
- The observed increases in color segregants were attributed to mitotic crossing-over, not non-disjunction.
- Bleomycin treatment led to a substantial (30-fold or more) increase in methionine-independent mutants, demonstrating its mutagenic potential.
Conclusions:
- Bleomycin acts as a potent inducer of mitotic recombination in Aspergillus nidulans.
- The drug also effectively induces point mutations within specific genetic loci.
- These findings highlight bleomycin's genotoxic effects and its utility in studying DNA damage and repair mechanisms.